Several possible studies
Story checked
What Is Ozempic Face? Causes, Symptoms, and Treatment (opens in a new tab)
webmd.com · 2024-07-12
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
What Is Ozempic Face? Causes, Symptoms, and Treatment
webmd.com · 2024-07-12
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checked“Ozempic face” is a popular term for the appearance of the face after weight loss, especially weight loss that happens after taking Ozempic or similar medication.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedThe term refers to a hollowness in the cheeks or extra skin that can appear when facial fat is lost, and it is not a medical term.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedFacial effects like hollowness, wrinkles, sunken eyes, and sagging skin can happen after rapid weight loss from Ozempic or similar drugs, or from rapid weight loss in general.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedThe article says rapid or substantial weight loss can leave less fat under the skin, so extra skin may hang loose where fat once filled out the face; slower weight loss may make facial changes less noticeable.View evidenceHide evidence
As statedOn average, people who take Ozempic for weight loss lose about 11% of their body fat within six months.
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedThe article says the facial appearance may return if weight is regained, and various cosmetic procedures can restore some volume if a person wants treatment.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Beyond Skin Laxity: GLP-1 Receptor Agonist-Induced Lean Mass Depletion and Surgical Tissue Quality in Aesthetic Surgery: A Narrative Review.
Aesthetic Surgery Journal. Open Forum · 2026 · PubMed
Daily GLP-1 receptor agonist pill leads to ‘significant’ weight loss
Pharmaceutical Journal · 2025 · Crossref
Small-Molecule Oral Versus Injectable Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Comparative Efficacy, Safety, and Future Clinical Perspectives.
2026 · Europe PMC
Aesthetic Considerations for Preventing and Managing GLP-1 Receptor Agonist-Related Facial Aging.
The Journal of Clinical and Aesthetic Dermatology · 2026 · PubMed
Facial aging after GLP-1 receptor agonist–induced weight loss: the emerging Ozempic face phenomenon
Journal of Diabetes & Metabolic Disorders · 2025 · Crossref
And 10 more candidates considered.